JPH041747B2 - - Google Patents

Info

Publication number
JPH041747B2
JPH041747B2 JP61265436A JP26543686A JPH041747B2 JP H041747 B2 JPH041747 B2 JP H041747B2 JP 61265436 A JP61265436 A JP 61265436A JP 26543686 A JP26543686 A JP 26543686A JP H041747 B2 JPH041747 B2 JP H041747B2
Authority
JP
Japan
Prior art keywords
chloro
substituted
solution
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61265436A
Other languages
English (en)
Japanese (ja)
Other versions
JPS62114988A (ja
Inventor
Rakushumana Mirari Banauara
Robaato Raason Eritsuku
Jei Zemuburosukii Uiriamu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Original Assignee
Pfizer Corp Belgium
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium filed Critical Pfizer Corp Belgium
Publication of JPS62114988A publication Critical patent/JPS62114988A/ja
Publication of JPH041747B2 publication Critical patent/JPH041747B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP61265436A 1985-11-07 1986-11-07 複素環式オキソフタラジニル酢酸 Granted JPS62114988A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79603985A 1985-11-07 1985-11-07
US796359 1985-11-07
US796039 1985-11-07

Publications (2)

Publication Number Publication Date
JPS62114988A JPS62114988A (ja) 1987-05-26
JPH041747B2 true JPH041747B2 (fr) 1992-01-14

Family

ID=25167108

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61265436A Granted JPS62114988A (ja) 1985-11-07 1986-11-07 複素環式オキソフタラジニル酢酸

Country Status (5)

Country Link
JP (1) JPS62114988A (fr)
CA (1) CA1299178C (fr)
DD (1) DD254001A5 (fr)
PH (1) PH26741A (fr)
ZA (1) ZA868450B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87709A (en) * 1987-09-16 1992-11-15 Pfizer Process for preparing haloalkyl thiazoles and some such novel haloalkyl thiazoles
EP0322153A3 (fr) * 1987-12-21 1990-08-16 Pfizer Inc. Acides hétérocyclyl oxophtalazinyl acétiques
US4954629A (en) * 1989-05-11 1990-09-04 Pfizer Inc. Process and intermediates for the preparation of oxophthalazinyl acetic acids and analogs thereof
US8916563B2 (en) 2010-07-16 2014-12-23 The Trustees Of Columbia University In The City Of New York Aldose reductase inhibitors and uses thereof
EP2593456B1 (fr) * 2010-07-16 2016-11-30 The Trustees of Columbia University in the City of New York Inhibiteurs de l'aldose réductase et leurs utilisations
EP3352754B1 (fr) 2016-06-21 2020-09-02 The Trustees of Columbia University in the City of New York Inhibiteurs d'aldose réductase et procédés d'utilisation associés
IL272246B2 (en) * 2017-07-28 2026-01-01 Applied Therapeutics Inc History of 2-(4-oxo/thioketone/azo-3-((substituted)benzo[d]thiazol-2-yl)methyl)- 3,4-dihydrothieno[3,4-d]pyridazin-1-yl)acetic acid for use as an aldose reductase inhibitor for the treatment of galactosemia or prevention of galactosemia-related complications
KR20220003529A (ko) * 2019-04-01 2022-01-10 어플라이드 테라퓨틱스 인크. 알도스 리덕타제의 억제제
MX2021013511A (es) 2019-05-07 2022-02-23 Univ Miami Tratamiento y deteccion de neuropatias heredadas y trastornos asociados.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS=73 *

Also Published As

Publication number Publication date
PH26741A (en) 1992-09-28
DD254001A5 (de) 1988-02-10
JPS62114988A (ja) 1987-05-26
CA1299178C (fr) 1992-04-21
ZA868450B (en) 1988-06-29

Similar Documents

Publication Publication Date Title
KR890002758B1 (ko) 헤테로시클릭 옥소프탈라지닐 아세트산 및 그의 제조 방법
US4939140A (en) Heterocyclic oxophthalazinyl acetic acids
RU2059627C1 (ru) Бициклическое гетероциклическое соединение и фармацевтическая композиция
US4933336A (en) Thiadiazinone, oxadiazinone and triazinone derivatives, and their use for treating acute or chronic heart disease
JPH04243877A (ja) チオキソ複素環式化合物、その製造方法、ロイコトリエンが介在する疾患および症状の治療において使用するためのこの化合物を有する医薬品
JP5528348B2 (ja) 縮合環化合物およびその用途
HUT77609A (hu) Azolszármazékok, az ezeket tartalmazó gyógyszerkészítmények és a vegyületek intermedierjei
EP0401981B1 (fr) Dérivés de pyridazinone
JPH041747B2 (fr)
JP3122469B2 (ja) 抗精神病剤としてのピリジンイミニル−１，２−ベイゾイソオキサゾール類及び−ベンゾイソチアゾール類
JPH0338569A (ja) 喘息、関節炎及び関連疾患の治療における置換スルホンアミド及び関連化合物
JPH0660163B2 (ja) 置換オキソフタラジニル酢酸およびその同族体
US6001867A (en) 1-aryl-dibenzothiophenes
JP2000508299A (ja) 抗ウイルス作用を有する置換キノリン誘導体
CA1299181C (fr) Acides oxophtalazinylacetiques heterocycliques
JP2005089298A (ja) ナフタレン化合物及びその医薬用途
IE61943B1 (en) 1H-indazole-3-acetic acids as aldose reductase inhibitors
JPS6332069B2 (fr)
CZ387092A3 (en) Pyridazinoacetic acids, their derivatives, process of their preparation and use
WO2004058742A1 (fr) Composes de benzocycloheptapyridine
HU211314A9 (hu) Heterociklusos oxoftalazinil-ecetsavak
HU206338B (en) Process for producing 3-/heterocyclic-methyl-or-heterocyclic-thio-methyl/-4-oxo- -phtalazinyl-1-acetic acid derivatives and pharmaceutical compositions containing them
JPH0249792A (ja) スルフェンアミド誘導体
NO885771L (no) Fremgangsmaate for fremstilling av heterocykliske oksoftalazinyl-eddiksyrer.

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees